Press Releases on February 26, 2020 - EIN Presswire - Press Release Distribution Service

Published on February 26, 2020 - 12:00 GMT

Iowa US Navy Veterans Mesothelioma Advocate Has Endorsed Attorney Erik Karst of Karst von Oiste to Make Certain a Navy Veteran ...

DES MOINES , IOWA, USA, February 26, 2020 /⁨EINPresswire.com⁩/ -- The Iowa US Navy Veterans Mesothelioma Advocate has endorsed attorney Erik Karst and his remarkable colleagues at the law firm of Karst von Oiste to ensure a Navy Veteran with …

Distribution channels: Agriculture, Farming & Forestry Industry, Automotive Industry ...

Published on February 26, 2020 - 12:00 GMT

RegScan Launching Artificial Intelligence, Mobile, Enhanced Compliance Research

WILLIAMSPORT, PA, UNITED STATES, February 26, 2020 /⁨EINPresswire.com⁩/ -- RegScan, Inc., a compliance management company, is launching a new regulatory platform. The new platform has a mobile-friendly interface which allows you to easily access the …

Distribution channels: Companies, Environment ...

Published on February 26, 2020 - 12:00 GMT

ProQR Announces Fourth Quarter and Full Year 2019 Results and Provides Business Update

Substantial progress in 2019 with final data from Phase 1/2 trial of sepofarsen for Leber’s congenital amaurosis 10 showing rapid, significant and durable improvements in vision; Phase 2/3 pivotal trial Illuminate initiated with data expected in H1 2021 …

Distribution channels:

Published on February 26, 2020 - 12:00 GMT

Summit Appoints Robert W. Duggan as Executive Chairman

Summit Therapeutics plc (‘Summit’ or the ‘Company’) Summit Appoints Robert W. Duggan as Executive Chairman Oxford, UK, and Cambridge, MA, US, 26 February 2020 – Summit Therapeutics plc (NASDAQ: SMMT) today announces it has appointed Robert W. Duggan as …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...

Published on February 26, 2020 - 12:00 GMT

Orchard Therapeutics to Present at Investor Conferences in March

BOSTON and LONDON, Feb. 26, 2020 (GLOBE NEWSWIRE) -- Orchard Therapeutics (Nasdaq: ORTX), a global leader in gene therapy, today announced that members of the management team will present at the following investor conferences in March: Cowen 40th Annual …

Distribution channels: Culture, Society & Lifestyle, Technology ...

Published on February 26, 2020 - 12:00 GMT

Antares Pharma to Present at the Cowen and Company 40th Annual Health Care Conference

EWING, N.J., Feb. 26, 2020 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) today announced that Robert F. Apple, President and Chief Executive Officer, will present at the Cowen and Company 40th Annual Health Care Conference on Wednesday March 4, …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...

Published on February 26, 2020 - 12:00 GMT

Akcea Therapeutics to Present at the Cowen 40th Annual Health Care Conference

BOSTON, Feb. 26, 2020 (GLOBE NEWSWIRE) -- Akcea Therapeutics, Inc. (NASDAQ:AKCA), a majority-owned affiliate of Ionis Pharmaceuticals, Inc., focused on developing and commercializing drugs to treat patients with serious and rare diseases, today announced …

Distribution channels: Culture, Society & Lifestyle, Technology ...

Published on February 26, 2020 - 12:00 GMT

Apellis Pharmaceuticals to Present at the 40th Annual Cowen Health Care Conference

WALTHAM, Mass., Feb. 26, 2020 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS), a global biopharmaceutical company pioneering targeted C3 therapies, today announced that the company will present at the 40th Annual Cowen Health Care …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...

Published on February 26, 2020 - 12:00 GMT

Landos Biopharma to Present at the Cowen and Company 40th Annual Health Care Conference

BLACKSBURG, Va., Feb. 26, 2020 (GLOBE NEWSWIRE) -- Landos Biopharma, a clinical-stage biopharmaceutical company focused on the discovery and development of therapeutics for patients with autoimmune diseases, today announced that Dr. Josep Bassaganya-Riera, …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...

Published on February 26, 2020 - 12:00 GMT

RTI Surgical® Releases Data on the SImmetry® System Showing 98% of Treated SI Joints Demonstrate Evidence of Fusion

DEERFIELD, Ill., Feb. 26, 2020 (GLOBE NEWSWIRE) -- RTI Surgical Holdings, Inc. (Nasdaq: RTIX), a global surgical implant company, will showcase its expanding body of clinical data on the SImmetry® Sacroiliac Joint Fusion System at the 2020 International …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...

Published on February 26, 2020 - 12:00 GMT

IRADIMED CORPORATION Announces Retirement of Francis Casey and the Appointment of Steven Kachelmeyer as Vice President of ...

WINTER SPRINGS, Fla., Feb. 26, 2020 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced the retirement of Francis Casey, Vice President of Regulatory Affairs and Quality Assurance, effective June 30, 2020 after leading the Company’s …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...

Published on February 26, 2020 - 12:00 GMT

Tonix Pharmaceuticals Announces Research Collaboration with Southern Research to Develop a Potential Vaccine to Protect Against ...

NEW YORK, Feb. 26, 2020 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, announced today a strategic collaboration with Southern Research to support the development …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...

Published on February 26, 2020 - 12:00 GMT

BioXcel Therapeutics to Present at Two Upcoming Healthcare Investor Conferences

NEW HAVEN, Conn., Feb. 26, 2020 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (“BTI” or “Company”) (Nasdaq: BTAI), a clinical-stage biopharmaceutical company utilizing artificial intelligence to identify improved therapies in neuroscience and immuno- …

Distribution channels:

Published on February 26, 2020 - 12:00 GMT

Fossil Group, Inc. Reports Fourth Quarter and Full Year 2019 Results; Provides 2020 Financial Guidance

RICHARDSON, Texas, Feb. 26, 2020 (GLOBE NEWSWIRE) -- Fossil Group, Inc. (NASDAQ: FOSL) today announced financial results for the fourth quarter and fiscal year ended December 28, 2019. Fourth Quarter Financial Overview Worldwide net sales of $712 million …

Distribution channels: Business & Economy, Consumer Goods ...

Published on February 26, 2020 - 12:00 GMT

Harsco Appoints David Stanton to Lead Its Clean Earth Division

CAMP HILL, Pa., Feb. 26, 2020 (GLOBE NEWSWIRE) -- Harsco Corporation (NYSE: HSC) announced today the appointment of David Stanton as President of its Clean Earth division, effective March 2. In this role, Mr. Stanton will be responsible for leading the …

Distribution channels: Automotive Industry, Companies ...

Published on February 26, 2020 - 12:00 GMT

AMC Networks Inc. Reports Full Year and Fourth Quarter 2019 Results

Full Year Financial Highlights: Revenues of $3.1 billion Operating income of $625 million; Adjusted Operating Income1 of $944 million Diluted EPS of $6.67; Adjusted EPS1 of $9.27 Cash Provided by Operating Activities of $484 million; Free Cash Flow1 of $ …

Distribution channels: Business & Economy ...

Published on February 26, 2020 - 12:00 GMT

Fulcrum Therapeutics Announces Completion of Enrollment in Phase 2b Trial of Losmapimod for the Treatment of Facioscapulohumeral ...

Topline data on track for 3Q 2020 Dosing Initiated in ReDUX4 Open Label Extension CAMBRIDGE, Mass., Feb. 26, 2020 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc. (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on improving the lives of …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on February 26, 2020 - 12:00 GMT

Voyageur Pharmaceuticals Announces its “From The Earth To The Bottle” Iodine Contrast Strategy

CALGARY, Alberta, Feb. 26, 2020 (GLOBE NEWSWIRE) -- Voyageur Pharmaceuticals Ltd. (TSX.V:VM, USA:VYYRF) (the “Company” or “Voyageur”) is pleased to announce the fully-integrated iodine business strategy which complements its ongoing barium contrast …

Distribution channels: Media, Advertising & PR, Mining Industry ...

Published on February 26, 2020 - 12:00 GMT

Momenta Pharmaceuticals Reports Fourth Quarter and Full Year 2019 Financial Results

-- Reported favorable interim data from Phase 1/2 study of M254 in ITP, supporting expansion of Part B; expect to report updated data in Q2 2020 and launch additional Phase 2 study in CIDP in Q4 2020 -- -- Target enrollment completed in nipocalimab …

Distribution channels:

Published on February 26, 2020 - 12:00 GMT

Forty per cent of Canadians believe distracted driving is the number one cause of car-related deaths, national survey reveals

TORONTO, Feb. 26, 2020 (GLOBE NEWSWIRE) -- A recent survey from Rates.ca indicates that 40 per cent of Canadians believe distracted driving is the number one threat of car-related deaths, surpassing impaired driving (33 per cent) as the leading factor. …

Distribution channels: